New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline acid tartrate 0.0091 mg/ml equivalent to 5 µg/ml adrenaline;  ; lidocaine hydrochloride 10 mg/ml; adrenaline acid tartrate 0.0091 mg/ml ([=5mcg/ml adrenaline]); lidocaine hydrochloride 10 mg/ml; adrenaline acid tartrate 0.0091 mg/ml ([=5mcg/ml adrenaline]); lidocaine hydrochloride 10 mg/ml - solution for injection - active: adrenaline acid tartrate 0.0091 mg/ml equivalent to 5 µg/ml adrenaline   lidocaine hydrochloride 10 mg/ml excipient: hydrochloric acid as 2m solution for ph adjustment (ph 3.3-5.0) methyl hydroxybenzoate sodium chloride sodium hydroxide as 2m solution for ph adjustment (ph 3.3-5.0) sodium metabisulfite water for injection active: adrenaline acid tartrate 0.0091 mg/ml ([=5mcg/ml adrenaline]) lidocaine hydrochloride 10 mg/ml excipient: carbon dioxide hydrochloric acid sodium chloride sodium metabisulfite water for injection active: adrenaline acid tartrate 0.0091 mg/ml ([=5mcg/ml adrenaline]) lidocaine hydrochloride 10 mg/ml excipient: carbon dioxide hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: · local infiltration · minor or major nerve blocks · epidural block · arthroscopy · intravenous regional anaesthesia

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous; lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous; lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous; lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous - solution for injection - 2 % - active: lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid as 2m solution for ph adjustment to ph 6.7-6.8 methyl hydroxybenzoate sodium chloride sodium hydroxide as 2m solution for ph adjustment to ph 6.7-.68 water for injection active: lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: sodium chloride sodium hydroxide as 2m solution for ph adjustment water for injection active: lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: sodium chloride sodium hydroxide as 2m solution for ph adjustment water for injection active: lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid sodium chloride sodium hydroxide as 2m solution for ph adjustment water for injection - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: - local infiltration - minor or major nerve blocks - epidural block - arthroscopy - intravenous regional anaesthesia

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline acid tartrate 0.0091 mg/ml;  ; lidocaine hydrochloride 20 mg/ml; adrenaline acid tartrate 0.0091 mg/ml; lidocaine hydrochloride 20 mg/ml - solution for injection - active: adrenaline acid tartrate 0.0091 mg/ml   lidocaine hydrochloride 20 mg/ml excipient: hydrochloric acid sodium chloride sodium metabisulfite water for injection active: adrenaline acid tartrate 0.0091 mg/ml lidocaine hydrochloride 20 mg/ml excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: · local infiltration · minor or major nerve blocks · epidural block · arthroscopy · intravenous regional anaesthesia

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - lidocaine hydrochloride monohydrate 21.3 mg/ml equivalent to 20 mg lignocaine hydrochloride anhydrous - oral solution - 2% w/v - active: lidocaine hydrochloride monohydrate 21.3 mg/ml equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: carmellose sodium cherry extract fache 5913g methyl hydroxybenzoate propyl hydroxybenzoate purified water saccharin sodium sodium hydroxide - xylocaine viscous solution is indicated for the relief of pain and discomfort associated with: · irritated or inflamed mucous membranes of the mouth, pharynx and upper gastrointestinal tract, e.g. post-tonsillectomy sore throat, dumping syndrome · introduction of instruments and catheters into the respiratory and gastrointestinal tract.

Australia - English - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - lignocaine hydrochloride anhydrous; adrenaline acid tartrate; lignocaine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - lignocaine hydrochloride anhydrous; adrenaline acid tartrate; lignocaine hydrochloride -

Singapore - English - HSA (Health Sciences Authority)

dch auriga singapore - lidocaine - ointment - 50 mg/g - lidocaine 5g/100g

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine, quantity: 100 mg/ml - spray, solution - excipient ingredients: ethanol; menthol; purified water; macrogol 400; saccharin; flavour - xylocaine 10% pump spray is used for surface anaesthesia of the mucous membranes prior to the following procedures:,otorhinolaryngology:,to prepare for puncture of the maxillary sinus; for analgesia of the pharynx to prevent gagging and stress reactions when inserting instruments.,dental practice:,before injections, treating minor abscesses, suture removal, deep scaling and to prevent gagging when taking intraoral impressions and x-rays.,general anaesthesia:,to prevent coughing with an endotracheal tube in situ during light surgical anaesthesia.,obstetrics:,during the final stages of delivery and before episiotomy and perineal suturing as supplementary pain control.

Ireland - English - HPRA (Health Products Regulatory Authority)

dentsply detrey gmbh - lidocaine hydrochloride; adrenaline (epinephrine) tartrate - solution for injection - 2 percent weight/volume - amides; prilocaine

Australia - English - Department of Health (Therapeutic Goods Administration)

dentsply (australia) pty ltd - lignocaine hydrochloride; adrenaline acid tartrate -